Skip to content

Drug interactions

Encorafenib + Haloperidol

Severity: Major

Encorafenib and Haloperidol: major interaction.

Last updated Sources: US FDA label

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Both drugs can prolong the QTc interval, so combined use may increase the risk of torsades de pointes. The risk is greater with electrolyte abnormalities or other QT-prolonging drugs.

What this interaction means in plain words

Encorafenib and Haloperidol can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Encorafenib belongs to Oncology; Haloperidol belongs to Central Nervous System.

Evidence level: Moderate

Why it happens

Additive delayed cardiac repolarization through QT-prolonging effects of both drugs.

What to do

Avoid if an alternative exists. Otherwise obtain a baseline ECG, correct potassium and magnesium, and repeat the ECG during treatment.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Encorafenib and Haloperidol, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

References

Frequently asked questions

Can I take Encorafenib with Haloperidol?

MediHelp rates the interaction as major. Encorafenib and Haloperidol can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Both drugs can prolong the QTc interval, so combined use may increase the risk of torsades de pointes. The risk is greater with electrolyte abnormalities or other QT-prolonging drugs.

How serious is the interaction between Encorafenib and Haloperidol?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid if an alternative exists. Otherwise obtain a baseline ECG, correct potassium and magnesium, and repeat the ECG during treatment.

What other medicines interact with Haloperidol?

MediHelp also lists interactions of Haloperidol with, for example, Dofetilide, Dronedarone, Ibutilide. The full list is on the Haloperidol page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in